These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9052413)

  • 61. Flow cytometry as an adjunct to cytomorphologic analysis of serous effusions.
    Czader M; Ali SZ
    Diagn Cytopathol; 2003 Aug; 29(2):74-8. PubMed ID: 12889043
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Tumor markers in the diagnosis of ascitic and pleural puncture fluids].
    Mezger J; Lamerz R; Arnholdt H; Huhn D; Wilmanns W
    Onkologie; 1986 Feb; 9(1):11-6. PubMed ID: 3523341
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma.
    Kohno N; Akiyama M; Kyoizumi S; Hakoda M; Kobuke K; Yamakido M
    Jpn J Clin Oncol; 1988 Sep; 18(3):203-16. PubMed ID: 3411786
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Carcinoma of ovarian and other origins in effusions. Immunocytochemical study with a panel of monoclonal antibodies.
    Flynn MK; Johnston W; Bigner S
    Acta Cytol; 1993; 37(4):439-47. PubMed ID: 8328236
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The role of liquid-based cytology and ancillary techniques in pleural and pericardic effusions: an institutional experience.
    Rossi ED; Bizzarro T; Schmitt F; Longatto-Filho A
    Cancer Cytopathol; 2015 Apr; 123(4):258-66. PubMed ID: 25641902
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Small cell carcinoma versus other lung malignancies: diagnosis by fine-needle aspiration cytology.
    Delgado PI; Jorda M; Ganjei-Azar P
    Cancer; 2000 Oct; 90(5):279-85. PubMed ID: 11038424
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Malignant effusions: from diagnosis to biology.
    Davidson B
    Diagn Cytopathol; 2004 Oct; 31(4):246-54. PubMed ID: 15452897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Survival of patients with malignancy-associated effusions.
    van de Molengraft FJ; Vooijs GP
    Acta Cytol; 1989; 33(6):911-6. PubMed ID: 2588923
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The possibility of applying a monoclonal tumor-restricted antibody in cytologic diagnosis of lung cancer in serous effusions.
    Cappellari A; Bagarella M; Corradi G
    Biomed Pharmacother; 1990; 44(5):277-80. PubMed ID: 2091810
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Cytopathology of extramedullary hemopoiesis in effusions and peritoneal washings: a report of three cases with immunohistochemical study.
    Yazdi HM
    Diagn Cytopathol; 1986 Dec; 2(4):326-9. PubMed ID: 3539563
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunocytochemical staining of proliferating cells in fine needle aspiration smears of primary and metastatic breast tumours.
    Kuenen-Boumeester V; Blonk DI; Van der Kwast TH
    Br J Cancer; 1988 May; 57(5):509-11. PubMed ID: 3395556
    [No Abstract]   [Full Text] [Related]  

  • 72. Changing utilization of cytopathology versus histopathology in the diagnosis of lung cancer.
    Fraire AE; McLarty JW; Greenberg SD
    Diagn Cytopathol; 1991; 7(4):359-62. PubMed ID: 1935513
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Immunohistochemical panel for distinguishing between carcinoma and reactive mesothelial cells in serious effusions.
    Lee JS; Nam JH; Lee MC; Park CS; Juhng SW
    Acta Cytol; 1996; 40(4):631-6. PubMed ID: 8693877
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Comparative study of the expression of CEA and a myelomonocytic antigen (CD15) in serous effusions using two monoclonal antibodies NEO 723 and Leu M1].
    Daste G; Berthier F; Mauduyt MA; Soleilhavoup JP
    Arch Anat Cytol Pathol; 1992; 40(4):183-9. PubMed ID: 1294046
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Identification of second malignancies on effusions and fine-needle aspirates using a panel of monoclonal antibodies.
    Mottolese M; Venturo I; Rinaldi M; Lopez M; Bigotti G; Benevolo M; Natali PG
    Br J Cancer; 1997; 75(4):572-8. PubMed ID: 9052413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Use of selected combinations of monoclonal antibodies to tumor associated antigens in the diagnosis of neoplastic effusions of unknown origin.
    Mottolese M; Venturo I; Donnorso RP; Curcio CG; Rinaldi M; Natali PG
    Eur J Cancer Clin Oncol; 1988 Aug; 24(8):1277-84. PubMed ID: 3053205
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Selected monoclonal antibodies can increase the accuracy of cytodiagnosis of neoplastic effusions of cryptic origin expanded in a short term culture.
    Mottolese M; Cianciulli A; Venturo I; Perrone Donnorso R; Salzano M; Benevolo M; Bigotti G; Natali PG
    Diagn Cytopathol; 1992; 8(2):153-60. PubMed ID: 1568412
    [TBL] [Abstract][Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.